SQZ Biotechnologies Co Human Resources Contracts & Agreements
25 Contracts & Agreements
- Bonus & Incentive Agreements (4 contracts)
- Compensation Agreements (3)
- Consulting Agreements (2)
- Employment Agreements (9)
- Separation Agreements (3)
- Transition Agreements (4)
- Transition Agreement between the Registrant and Marshelle Smith Warren, dated October 3, 2023 (Filed With SEC on November 8, 2023)
- Transition Agreement between the Registrant and Lawrence Knopf, dated October 3, 2023 (Filed With SEC on November 8, 2023)
- Transition Agreement between the Registrant and Richard Capasso, dated October 3, 2023 (Filed With SEC on November 8, 2023)
- Transition Agreement between the Registrant and Howard Bernstein, dated October 3, 2023 (Filed With SEC on November 8, 2023)
- Amended Non-Employee Director Compensation Program (Filed With SEC on November 8, 2023)
- Form of Retention Recognition Bonus Letter for Executive Employees (Filed With SEC on July 7, 2023)
- Transition Consulting Agreement between SQZ Biotechnologies Company and Howard Bernstein, dated November 1, 2022 (Filed With SEC on November 9, 2022)
- Separation Agreement between SQZ Biotechnologies Company and Howard Bernstein, dated September 2, 2022 (Filed With SEC on November 9, 2022)
- Employment Agreement between SQZ Biotechnologies Company and Marshelle Smith Warren, dated May 25, 2022 (Filed With SEC on August 4, 2022)
- Employment Agreement between SQZ Biotechnologies Company and Micah Zajic, dated July 7, 2022 (Filed With SEC on July 11, 2022)
- Transition Consulting Agreement between the Registrant and Teri Loxam, dated November 11, 2021 (Filed With SEC on March 16, 2022)
- Separation Agreement between the Registrant and Teri Loxam, dated November 3, 2021 (Filed With SEC on March 16, 2022)
- Employment Agreement between the Registrant and David First, dated October 29, 2020 (Filed With SEC on March 16, 2022)
- Employment Agreement between the Registrant and Howard Bernstein, dated October 29, 2020 (Filed With SEC on March 16, 2022)
- Amended Non-Employee Director Compensation Program (Filed With SEC on March 16, 2022)
- Separation Agreement between Oliver Rosen and SQZ Biotechnologies Company, dated September 2, 2021 (Filed With SEC on November 10, 2021)
- Employment Agreement between the Registrant and Micah Zajic, dated October 29, 2020 (Filed With SEC on February 9, 2021)
- Employment Agreement between the Registrant and Lawrence Knopf, dated October 29, 2020 (Filed With SEC on February 9, 2021)
- Employment Agreement between the Registrant and Armon Sharei, Ph.D., dated October 23, 2020 (Filed With SEC on October 26, 2020)
- Employment Agreement between the Registrant and Oliver Rosen, M.D., dated October 23, 2020 (Filed With SEC on October 26, 2020)
- Employment Agreement between the Registrant and Teri Loxam, dated October 23, 2020 (Filed With SEC on October 26, 2020)
- Non-Employee Director Compensation Program (Filed With SEC on October 26, 2020)
- 2020 Incentive Award Plan and form of agreements thereunder (Filed With SEC on October 26, 2020)
- 2014 Stock Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on October 26, 2020)
- 2014 Stock Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on October 9, 2020)
